Originalkatalog | Verfügbarkeit prüfen

P576 Real-world effectiveness and safety of risankizumab in patients with moderate-to-severe multi-refractory Crohn’s disease: a Belgian multi-centric cohort study

Alsoud, D, Franchimont, D, D’Heygere, F, Bossuyt, P, Vijverman, A, Van Hootegem, P, Sabino, J, Cremer, A, Vermeire, S, Ferrante, M
Veröffentlicht in: Journal of Crohn's and Colitis ; volume 16, issue Supplement_1, page i516-i517 ; ISSN 1873-9946 1876-4479;
2022

Originalkatalog | Verfügbarkeit prüfen

DOP069 Natural history of dysplasia and colorectal cancer in IBD patients in Belgium tertiary care centers

Cremer, A., Liefferinckx, C., De Vos, M., Rahier, J.-F., Baert, F., Moreels, T., Macken, E., Louis, E., Devière, J., Van Gossum, A., Vermeire, S., Franchimont, D.
Veröffentlicht in: Journal of Crohn's and Colitis ; volume 11, issue suppl_1, page S67-S67 ; ISSN 1873-9946 1876-4479;
2017

Originalkatalog | Verfügbarkeit prüfen

Belgian IBD research group (BIRD) position statement 2017 on the use of biosimilars in inflammatory bowel diseases (IBD).

Franchimont, D., Ferrante, M., Louis, Edouard, De Vos, M., Dewit, O., Van Hootegem, P., Moreels, T., Liefferinckx, C., Bossuyt, P., Baert, F., Rahier, Jean-François, Vermeire, S.
2018

Originalkatalog | Verfügbarkeit prüfen

DOP003 Ustekinumab induces clinical and biological remission in biologic refractory Crohn’s disease patients: A real-world belgian cohort study

Liefferinckx, C, Verstockt, B, Gils, A, Noman, M, Van Kemseke, C, Macken, E, De Vos, M, Van Moerkercke, W, Rahier, J -F, Bossuyt, P, Dutré, J, Humblet, E, Staessen, D, Peeters, H, Van Hootegem, P, Louis, E, Franchimont, D, Baert, F, Vermeire, S
Veröffentlicht in: Journal of Crohn's and Colitis ; volume 12, issue supplement_1, page S031-S032 ; ISSN 1873-9946 1876-4479;
2018

Originalkatalog | Verfügbarkeit prüfen

P422 Tofacitinib induces clinical and endoscopic remission in biologic refractory ulcerative colitis patients: a real-world Belgian cohort study

Cremer, A, Lobaton, T, Vieujan, S, Bossuyt, P, Rahier, J F, Baert, F, Dewit, O, Somers, M, Macken, E, Vijverman, A, Van Hootegem, P, Mana, F, Willandt, B, Caenepeel, P, Humblet, E, D’Heygere, F, Verreth, A, El Nawar, A, Coenegrachts, J L, Dewit, S, De Coninck, S, Schoofs, N, Delen, S, Dutre, J, Thienpont, C, Vanden Branden, S, Staessen, D, Franchimont, D
Veröffentlicht in: Journal of Crohn's and Colitis ; volume 14, issue Supplement_1, page S384-S386 ; ISSN 1873-9946 1876-4479;
2020

Originalkatalog | Verfügbarkeit prüfen

Incidence and Predictors of Success of Adalimumab Dose Escalation and De-escalation in Ulcerative Colitis: a Real-World Belgian Cohort Study

Van de Vondel, Saartje, Baert, Filip, Reenaers, Christine, Vanden Branden, Stijn, Amininejad, Leila, Dewint, Pieter, Van Moerkercke, Wouter, Rahier, Jean-François, Hindryckx, Pieter, Bossuyt, Peter, Ferrante, Marc, Baert, F, De Wulf, D, Moortgat, L, De Cock, E, Decaestecker, L, D’Hondt, A, Van Moerkercke, W, Himpe, S, Dewint, P, Reenaers, C, Van Kemzeke, C, Louis, E, Rahier, J F, Amininejad, L, Franchimont, D, Wambacq, V, Bossuyt, P, Van de Schoot, I, Asnong, K, Vanden Branden, S, Sterckx, A, Hindryckx, P, De Vos, M, Ferrante, M, Noman, M, Vermeire, S, Van Assche, G, Rahier, J -F
Veröffentlicht in: Inflammatory Bowel Diseases ; volume 24, issue 5, page 1099-1105 ; ISSN 1078-0998 1536-4844;
2018